Literature DB >> 24995971

Carbenoxolone induces permeability transition pore opening in rat mitochondria via the translocator protein TSPO and connexin43.

Tamara Azarashvili1, Yulia Baburina2, Dmitry Grachev3, Olga Krestinina4, Vassilios Papadopoulos5, John J Lemasters6, Irina Odinokova7, Georg Reiser8.   

Abstract

Ca(2+)-induced permeability transition pore (mPTP) opening in isolated rat brain mitochondria is promoted through targeting of connexin43. After a threshold Ca(2+) load, mitochondrial membrane potential drops and efflux of accumulated Ca(2+) from the mitochondrial matrix occurs, indicating the mPTP opening. Specific antibodies were used to assess the role of the translocator protein (18kDa; TSPO) and connexin43 in swelling of isolated rat liver and brain mitochondria induced by carbenoxolone and the endogenous TSPO ligand protoporphyrin IX. Mitochondrial membrane potential, Ca(2+) transport and oxygen consumption were determined using selective electrodes. All the parameters were detected simultaneously in a chamber with the selective electrodes. The phosphorylation state of mitochondrial protein targets was assessed. We report that Ca(2+)-induced mitochondrial swelling was strengthened in the presence of both carbenoxolone and protoporphyrin IX. The carbenoxolone- and protoporphyrin IX-accelerated mPTP induction in brain mitochondria was completely prevented by antibodies specific for the mitochondrial translocator protein (TSPO). The anti-TSPO antibodies were more effective than anti-сonnexin43 antibodies. Moreover, carbenoxolone-stimulated phosphorylation of mitochondrial proteins was inhibited by anti-TSPO antibodies. Taken together, the data suggests that, in addition to acting via connexion43, carbenoxolone may exert its effect on mPTP via mitochondrial outer membrane TSPO.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carbenoxolone; Connexins; Mitochondria; Permeability transition pore; Protoporphyrin IX; TSPO

Mesh:

Substances:

Year:  2014        PMID: 24995971      PMCID: PMC4547858          DOI: 10.1016/j.abb.2014.06.027

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  55 in total

1.  Rapid isolation of metabolically active mitochondria from rat brain and subregions using Percoll density gradient centrifugation.

Authors:  N R Sims
Journal:  J Neurochem       Date:  1990-08       Impact factor: 5.372

Review 2.  The molecular composition of the mitochondrial permeability transition pore.

Authors:  Christopher P Baines
Journal:  J Mol Cell Cardiol       Date:  2009-02-20       Impact factor: 5.000

3.  Studies on the phosphorylation of the 18 kDa mitochondrial benzodiazepine receptor protein.

Authors:  M E Whalin; N Boujrad; V Papadopoulos; K E Krueger
Journal:  J Recept Res       Date:  1994-05

4.  Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by flavonoids from licorice roots and 4-arylcoumarins.

Authors:  A Kusano; T Nikaido; T Kuge; T Ohmoto; G Delle Monache; B Botta; M Botta; T Saitoh
Journal:  Chem Pharm Bull (Tokyo)       Date:  1991-04       Impact factor: 1.645

5.  Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships.

Authors:  J S Davidson; I M Baumgarten
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

Review 6.  What is the mitochondrial permeability transition pore?

Authors:  Andrew P Halestrap
Journal:  J Mol Cell Cardiol       Date:  2009-03-03       Impact factor: 5.000

Review 7.  Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule.

Authors:  Jinjiang Fan; Jun Liu; Martine Culty; Vassilios Papadopoulos
Journal:  Prog Lipid Res       Date:  2010-01-04       Impact factor: 16.195

8.  Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex.

Authors:  Valentina Giorgio; Elena Bisetto; Maria Eugenia Soriano; Federica Dabbeni-Sala; Emy Basso; Valeria Petronilli; Michael A Forte; Paolo Bernardi; Giovanna Lippe
Journal:  J Biol Chem       Date:  2009-09-29       Impact factor: 5.157

9.  In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells.

Authors:  M Garnier; A B Dimchev; N Boujrad; J M Price; N A Musto; V Papadopoulos
Journal:  Mol Pharmacol       Date:  1994-02       Impact factor: 4.436

10.  Effect of peripheral benzodiazepine receptor (PBR/TSPO) ligands on opening of Ca2+-induced pore and phosphorylation of 3.5-kDa polypeptide in rat brain mitochondria.

Authors:  O V Krestinina; D E Grachev; I V Odinokova; G Reiser; Yu V Evtodienko; T S Azarashvili
Journal:  Biochemistry (Mosc)       Date:  2009-04       Impact factor: 2.487

View more
  5 in total

Review 1.  Translocator protein (18 kDa): an update on its function in steroidogenesis.

Authors:  V Papadopoulos; J Fan; B Zirkin
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

Review 2.  The changing landscape in translocator protein (TSPO) function.

Authors:  Vimal Selvaraj; Douglas M Stocco
Journal:  Trends Endocrinol Metab       Date:  2015-03-21       Impact factor: 12.015

3.  Effect of the CRAC Peptide, VLNYYVW, on mPTP Opening in Rat Brain and Liver Mitochondria.

Authors:  Tamara Azarashvili; Olga Krestinina; Yulia Baburina; Irina Odinokova; Vladimir Akatov; Igor Beletsky; John Lemasters; Vassilios Papadopoulos
Journal:  Int J Mol Sci       Date:  2016-12-13       Impact factor: 5.923

Review 4.  Connexins and Nitric Oxide Inside and Outside Mitochondria: Significance for Cardiac Protection and Adaptation.

Authors:  Maria Shvedova; Yana Anfinogenova; Sergey V Popov; Dmitriy N Atochin
Journal:  Front Physiol       Date:  2018-05-16       Impact factor: 4.566

5.  Inhibition of Connexin 43 and Phosphorylated NR2B in Spinal Astrocytes Attenuates Bone Cancer Pain in Mice.

Authors:  Hui Yang; Hui Yan; Xin Li; Jing Liu; Shousong Cao; Baisheng Huang; Dong Huang; Lixiang Wu
Journal:  Front Cell Neurosci       Date:  2018-05-08       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.